Harvard Business Review

AUGUST 3, 2016

On the other hand, M&As can also strengthen the market power of the combined entity, reducing competition in a way that harms consumers. This is especially true in pharmaceutical markets where new and affordable drugs can improve and even save the lives of many people. What’s the reason for this?

Innovation 8

Innovation Pharmaceuticals Company Price 8

Harvard Business Review

JULY 8, 2016

The difference between displacement (outperforming existing market incumbents at their own game) and disruption (changing the game) is strategically important, no matter how similar the pain they cause is. Drucker Forum 2016: The Entrepreneurial Society. Displacement generally is easier to combat than disruption.

Business Model 10

Business Model Innovation Company Apparel 10

Harvard Business Review

OCTOBER 22, 2013

In order to do this, your company needs a process to source radical ideas that can catapult your business to new heights, open up new markets, or bring in completely unfamiliar profit streams. Here are five power skills we discovered to help you find uncontested space. Develop Creative Discontent. Use Convergence Thinking.

Skills 8

Skills Power Six Sigma Disruptive Innovation 8

Harvard Business Review

OCTOBER 26, 2017

Long before the Industrial Revolution , Bologna used this combination of hydraulic power and technology to bring silkworm farming to Europe at scale. They are known for demonstrating a special sensitivity to the market needs of the specialized manufacturers who use their services. Moreover, a cluster can never be static.

Education 8

Education Pharmaceuticals Innovation Industry 8

Harvard Business Review

APRIL 2, 2018

There is an abundance of high-quality comparative effectiveness data for pharmaceuticals, largely because of the drug approval process, but there’s less data on the value of other expensive investments into health, such as doctor visits and hospitalizations.

Health Care 8

Health Care Insurance Pharmaceuticals Incentives 8

Harvard Business Review

OCTOBER 23, 2014

Actors in this ecosystem are increasingly working together rather than handing off information or tasks to the next entity in a linear process. That’s why pharmaceutical, biotechnology, and medical device companies need to define their relevance in this new health care ecosystem, and soon. They’re also sharing risk. But not for long.

Health Care 8

Health Care Pharmaceuticals Information Technology Supply Chain 8

Harvard Business Review

JANUARY 31, 2013

First we see major shifts in demand: developing economies such as China and India are morphing from the world's source of low-cost manufacturing capacity to the world's best market opportunities. On the innovation front, the opportunities are more diverse, but equally powerful. Innovations Are Changing The Way We Design Products.

Globalization 9

Globalization Supply Chain Pharmaceuticals McKinsey 9

Harvard Business Review

SEPTEMBER 13, 2016

Tribes in organizations tend to be small, and may cut across formal silos; they have their own power structure, and their own ways of rewarding and punishing deviance. To influence tribes in organizations, you have to give up control, and recognize that every change always goes through a process of localization as it gets executed.

Resistance 8

Resistance Influence Pharmaceuticals Bottom-up 8

Harvard Business Review

OCTOBER 26, 2015

A recent USC study shows that across multiple and diverse markets, industries are 25% more likely to be “highly concentrated” than they were 20 years ago. Yet at the same time, America’s largest companies are more than twice as likely to lose market share than in 1980. corporate consolidation.

Competitive Advantage 8

Competitive Advantage Pharmaceuticals Industry Trends 8

Harvard Business Review

JANUARY 15, 2013

He uses the refrigerated box car and its achievements in reducing food-borne illness and saving millions of lives in the process to make his point. Business will move the great masses of humanity forward with advancements in pharmaceuticals, materials, process, and technology — but it will almost always leave 10% behind.

Learning Curve 9

Learning Curve Advertising GDP Pharmaceuticals 9

Harvard Business Review

MAY 10, 2016

After all, if acquisitions pay off they can provide a transformational antidote to a slowing core market and declining margins. Gillette dominated the men’s shaving market with its Mach series of razors. ” This relatively simple approach is actually a powerful tool to help confirm or deny the potential for synergies.

Strategy 8

Strategy Company Biotechnology Franchising 8

Harvard Business Review

FEBRUARY 4, 2013

Most of us would say it's exceptionally hard, particularly when power is concentrated in a few incumbent companies with deeply rooted vested interests. But this focused power may be a benefit, not a risk. Just under 1,000 companies account for half of the world's market capitalization, Eccles notes.

EPS 8

EPS Innovation CEO Pharmaceuticals 8

Harvard Business Review

MARCH 16, 2015

Enrique Santacana of ABB North America, a power and automation-technology firm, voiced his concern this way: “An overarching issue was the exposure we had as a company,” Santacana explained, “For example, how information was being used or may be used in a way that was not conducive to good business practices.

CEO 8

CEO Stephenson Pharmaceuticals Globalization 8

Harvard Business Review

MAY 24, 2012

Pharmaceutical manufacturers, insurers, and retailers invest millions in risk avoidance. Every business day, companies cede hard evidence to the political agendas of a willful manager or department, and these companies span geographies, industries, revenues, and market segments. Risk management isn't exclusive to banking.

Merchandising 11

Merchandising Risk Management Supply Chain Retail 11

Harvard Business Review

JUNE 16, 2011

Investors grapple daily in an effort to figure out how to value companies whose accounting assets — things like land, capital, products, and licenses — don't adequately express their true market value. Marvelous, but if it's invisible, how do you see an intangible asset or collaboration, for that matter?

Intangible Assets 15

Intangible Assets Analysis Pharmaceuticals Innovation 15

Harvard Business Review

MAY 17, 2012

After producing an initial prototype — a stripped-down version of traditional incubators powered by electricity — they traveled to Nepal to test it in an urban hospital. Most importantly, priced at approximately $200, the Embrace portable infant warmer costs merely 1 percent of what incubators in Western markets cost.

Incubator 11

Incubator Business Model Entrepreneur Cost 11

Harvard Business Review

DECEMBER 27, 2013

Sure, the company was eventually both punished and sold (it’s now one of the fastest-growing pharmaceutical businesses in the U.S.). In it, he traces the intersection of science and marketing that''s made junk food so delicious, so profitable, and so very bad for you. But is it actually working?

Armstrong 8

Armstrong Long-term Short-term CEO 8

Harvard Business Review

MAY 16, 2011

True collaboration always has open-ended elements — ranging from precisely how new innovations will be implemented, to how products will fare in the market, and even to what priorities partners will pursue in the face of changes in the environment. This landscape is evolving rapidly, in ways not even Google could foresee.

Software 15

Software Licensing Long-term Telecommunications 15

Harvard Business Review

MAY 15, 2013

It also focuses our attention on the forces that shape behavior in organizations, and so highlights an important question: are all those forces (including structure, processes, and incentives) "culture" or is culture simply the behavioral outputs? "In Culture is a process of "sense-making" in organizations.

Incentives 8

Incentives Definition Pharmaceuticals System 8

Harvard Business Review

SEPTEMBER 4, 2015

However, CEOs often don’t have the career background and education that would equip them to personally lead the process of new product development. We found that, for pharmaceutical industry CEOs, there is a statistically significant relationship between a CEO’s specialist background and the firm’s performance.

CEO 8

CEO Innovation Pharmaceuticals Merchandising 8

Harvard Business Review

NOVEMBER 29, 2016

The emergence of big data, as well as advancements in data science approaches and technology, is providing pharmaceutical companies with an opportunity to gain novel insights that can enhance and accelerate drug development.

Pharmaceuticals 8

Pharmaceuticals Incubator Health Care Biotechnology 8

Harvard Business Review

OCTOBER 26, 2017

As a shared source of trust, it can extend the scope of digital transformation from a single company to the processes it shares with its suppliers, customers, and partners. A target use case will involve a process that spans multiple parties, with multiple parties writing data, and where there is a lack of trust.

Supply Chain 8

Supply Chain Content Power Transportation 8

Harvard Business Review

NOVEMBER 28, 2017

One of your executives comes to you with a proposal: she wants to lower the quality of service at the restaurants, reduce product safety standards, use deceptive marketing practices, lower employee pay, and adopt worse environmental practices. Why do anti-profit beliefs persist in a market society? But these effects were limited.

Company 8

Company Short-term Long-term Price 8

Harvard Business Review

JUNE 12, 2018

The pervasive adoption of mobile devices has driven an explosion of contextual user information, including geolocation data, which has become a valuable resource for marketers. However, a lack of technical skill sets among marketers has made it difficult for them to use this data (when they have access to it) effectively.

Short-term 8

Short-term Brand Long-term Media 8

Harvard Business Review

NOVEMBER 20, 2015

He is poised to become the leader in this segment of a multi-billion dollar market. Corporate procurement processes are opaque, secretive, and can be influenced by political pull as well as pure performance. Global supply chains can cut across many “cultures”: national, industry, technology, market segment, and more.

Supply Chain 8

Supply Chain Collins Golden Handcuff Pharmaceuticals 8

Harvard Business Review

NOVEMBER 19, 2018

In this article, I explain why many models are better than one and also describe three rules for how to construct your own powerful ensemble of models: spread attention broadly, boost predictions, and seek conflict. A model formally represents some domain or process, often using variables and mathematical formula. (In

Construction 12

Construction Venture Capitalist Price Guidelines 12

Harvard Business Review

AUGUST 5, 2013

A pharmaceuticals company we''ve been studying decided to deploy more than 20,000 iPads and other mobile devices to the global sales force to improve its engagement with doctors in emerging and developed markets. The Real Power of Enterprise Social Media Platforms. It has never before rolled out something at this speed.

Organization 8

Organization CIO Compliance CRM 8

Harvard Business Review

FEBRUARY 6, 2018

Consider its decision to pursue the market for pharmaceutical distribution, or the recent announcement that it will be teaming up with Berkshire Hathaway and JP Morgan Chase to create joint solutions for reducing the health care spending of more than 1 million employees and their families. .”

Health Care 10

Health Care Retail Operations Insurance 10

Skip Prichard

JANUARY 14, 2021

“Consumers today are tired of marketers and being constantly marketed to. Consumers today are tired of marketers and being constantly marketed to. How do different traditional value chain companies, who read your book, and want to change best start that process? ” -Erich Joachimsthaler.

Brand 96

Brand Insurance Participative Open-book 96

Harvard Business Review

JANUARY 10, 2013

billion due to derelict mortgage and foreclosure processes. initiative — prohibitions against off-label marketing under the False Claims Act — swept through the pharmaceutical industry. The most notable was Fannie Mae's $10.8 billion restatement. In another instance, a new enforcement.

Finance 8

Finance Banking Press Release Pharmaceuticals 8

Harvard Business Review

FEBRUARY 3, 2017

The business model of research-based pharmaceutical companies is under significant pressure. This strategy will tap potential growth in emerging markets, limit the risks of misconduct, and improve public trust in the industry. However, it also reflects stronger pressures to lower medicine costs in traditional pharmaceutical markets.

Reputation 8

Reputation Pharmaceuticals Price Business Model 8

Harvard Business Review

SEPTEMBER 11, 2014

That means new technologies and new competitors are hitting the market at an unprecedented rate. Finally, industries in the upper-right quadrant — such as software, pharmaceuticals, and medical equipment — face high uncertainty in both demand and technology. To illustrate this, consider that patent applications in the U.S.

Uncertainty 22

Uncertainty Industry Bottom-up Technology 22

Harvard Business Review

JUNE 30, 2014

Leaders don’t necessarily gain power by dint of high rank; they need to earn it every day. In the words of Empson and Alvehus they have gained “legitimacy to lead through market success.” It would be hard not to note the parallels to the workings of political parties and the delicate process of “seeking high office.”

Politics 8

Politics Pharmaceuticals Consultative Consensus 8

Harvard Business Review

MAY 17, 2016

Yet, as companies grow, promotions fall in line with corporate processes, complex “balanced” scorecards of performance, and regression to the mean. Distortion of decisions: A number of years ago we studied in detail how the most important decisions like product approvals were made at a large pharmaceutical firm.

Execution 10

Execution Bureaucracy Self-aware CEO 10

Harvard Business Review

JUNE 3, 2013

It''s a much more complex neurological process. Still, it can be short-circuited when we''re primed for distrust — for example, when we''re introduced to a new colleague, when leaders are sending mixed messages, when we sense a power struggle, or when we don''t feel heard. So how can we prime our brains for trust instead?

How To 8

How To Uncertainty Pharmaceuticals Banking 8

Harvard Business Review

JANUARY 4, 2017

For example, Ford’s River Rouge plant not only assembled cars but also made its own steel, glass, fabrics, power, and cement on-site. There are similar stories in the electronics industry, pet food, pharmaceuticals, and even national security. stock markets. Manufacturing used to be highly vertically integrated in the U.S.

Supply Chain 9

Supply Chain Productivity Products Company 9